Christopher J. Molineaux
Corporate Officer/Principal bei CALITHERA BIOSCIENCES, INC.
Profil
Christopher J.
Molineaux is currently the Senior Vice President-Development at Calithera Biosciences, Inc. He previously held positions such as Senior Director-Pharmacology at Praecis Pharmaceuticals, Inc., Senior Director-Drug Development at FibroGen, Inc., Vice President-Development at Proteolix, Inc., and President at Indstrat LLC.
He also worked as an Assistant Professor at Icahn School of Medicine at Mount Sinai and as a Research Manager-Toxicology at J&J Pharmacy.
He is the Chief Development Officer at BerGenBio ASA. Molineaux holds a doctorate from The Johns Hopkins University and an undergraduate degree from the University of Maryland.
Aktive Positionen von Christopher J. Molineaux
| Unternehmen | Position | Beginn |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Corporate Officer/Principal | 01.04.2013 |
Ehemalige bekannte Positionen von Christopher J. Molineaux
| Unternehmen | Position | Ende |
|---|---|---|
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Chief Tech/Sci/R&D Officer | 26.06.2009 |
| Indstrat LLC | President | 01.01.2013 |
| FIBROGEN, INC. | Corporate Officer/Principal | 01.01.2004 |
| J&J Pharmacy | Corporate Officer/Principal | 01.01.2000 |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Christopher J. Molineaux
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| BERGENBIO ASA | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
| J&J Pharmacy | |
| Indstrat LLC |
